Environmental Stress, Genes and Risk of Hypertension

环境压力、基因和高血压风险

基本信息

  • 批准号:
    7479054
  • 负责人:
  • 金额:
    $ 32.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

The objective of Project 2 is to ascertain how chronic environmental stress in combination with unfavorable genotypes via 2 new mechanistic pathways (hypothalamic-pituitary-adrenocortical [HPA] axis and oxidative stress) affects BP reactivity to acute stress and development of preclinical cardiovascular disease (CVD). The Project will study a cohort of 300 African Americans and 307 European Americans (mean age will be 25.5 yrs) who have been evaluated 14 times over a 17-year period. The continued follow-up of this cohort will allow us to examine the cumulative effects of environmental stress, genotypes and their interaction on the time course of the development of preclinical measures of CVD over a period of 22 years. Subjects will have hemodynamic measures and indices of HPA axis and oxidative stress assessed prior to and immediately following three acute laboratory challenges, as well as in the naturalistic field setting. Subjects will also have measures of preclinical CVD evaluated. Two key genes in each of the HPA and oxidative stress pathways will be assessed by a gene-wide approach with all variants within a candidate gene considered jointly. In context of the recent evidence suggesting that activation of HPA axis and oxidative stress play an important role in obesity related EH, we hypothesize that obesity will exacerbate the activation of these two pathways which are elevated by chronic environmental stress. Specific aims of Project 2 are to test the hypotheses that individuals from chronically stressful environments and/or with unfavorable genotypes will exhibit greater increases over time in HPA axis and oxidative stress response to acute stressors and chronic stress (i.e., natural environment assessment) and measures of preclinical CVD. Possible moderating influences of obesity will also be examined. We will also test the hypotheses that individuals with higher levels (when originally measured) and/or greater increases over time in HPA and oxidative stress responses to acute stress will exhibit higher levels of BP reactivity and measures of preclinical CVD. The long term objective of Project 2 is to improve the understanding of the way stress contributes to the development of EH. Findings will contribute to development of behavioral pharmacogenetic therapies which will include lifestyle interventions and pharmaceutical therapies in which the role of stress is taken into account. These efforts will result in more efficacious and personalized primary and secondary prevention approaches of EH and its co-morbidities.
项目2的目标是确定慢性环境压力如何与不利的 通过两条新的机制途径(下丘脑-垂体-肾上腺皮质[HPA]轴和氧化作用)实现的基因分型 应激)影响血压对急性应激的反应性和临床前心血管疾病(CVD)的发展。 该项目将研究300名非洲裔美国人和307名欧洲裔美国人(平均年龄为 25.5年),他们在17年的时间里接受了14次评估。这一队列的持续后续行动 将使我们能够检验环境压力、基因类型及其相互作用对 22年来心血管疾病临床前措施发展的时间进程。研究对象将 在此之前和之前评估HPA轴和氧化应激的血流动力学测量和指数 紧接在三个实验室的尖锐挑战之后,以及在自然主义的野外环境中。科目 还将对临床前心血管疾病的测量进行评估。HPA和氧化各有两个关键基因 应激途径将通过一个候选基因内的所有变异的全基因方法进行评估。 共同考虑。最近的证据表明,HPA轴的激活和氧化 压力在肥胖相关的高血压中起着重要的作用,我们假设肥胖会加剧 激活这两条因慢性环境应激而升高的通路。的具体目标 项目2是测试来自长期压力环境和/或有 随着时间的推移,不利的基因型会在HPA轴和氧化应激反应中表现出更大的增加 急性应激源和慢性应激(即自然环境评估)和临床前心血管疾病的措施。 此外,还将研究肥胖可能产生的缓解影响。我们还将检验假设 HPA和HPA水平较高(最初测量时)和/或随时间增加较多的个人 对急性应激的氧化应激反应将表现出更高水平的BP反应性和措施 临床前脑血管病。 项目2的长期目标是提高对压力对心理健康的影响的理解。 高血压病的发展。这些发现将有助于开发行为药物遗传疗法, 将包括生活方式干预和药物治疗,其中压力的作用被纳入 帐号。这些努力将产生更加有效和个性化的一级和二级预防。 高血压病及其并发症的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frank A Treiber其他文献

Ambulatory, Resting and Stress Hemodynamics: Contributions to Increased Left Ventricular Mass in Youth
动态、静息和应激血流动力学:对青少年左心室质量增加的贡献
  • DOI:
    10.1203/00006450-199904020-00133
  • 发表时间:
    1999-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Barton B Cook;Frank A Treiber;Harry S Davis;Gaston K Kapuku;William B Strong
  • 通讯作者:
    William B Strong

Frank A Treiber的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frank A Treiber', 18)}}的其他基金

Patient Centered Health Technology Medication Adherence Program for African American Hypertensives
以患者为中心的非裔美国人高血压健康技术药物依从计划
  • 批准号:
    9381307
  • 财政年份:
    2017
  • 资助金额:
    $ 32.14万
  • 项目类别:
Smartphone Medication Adherence Stops Hypertension (SMASH) Among Hispanics
坚持使用智能手机药物可阻止西班牙裔高血压 (SMASH)
  • 批准号:
    8702567
  • 财政年份:
    2014
  • 资助金额:
    $ 32.14万
  • 项目类别:
Smartphone Medication Adherence Stops Hypertension (SMASH) Among Hispanics
坚持使用智能手机药物可阻止西班牙裔高血压 (SMASH)
  • 批准号:
    8822912
  • 财政年份:
    2014
  • 资助金额:
    $ 32.14万
  • 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
  • 批准号:
    8506076
  • 财政年份:
    2013
  • 资助金额:
    $ 32.14万
  • 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
  • 批准号:
    8666040
  • 财政年份:
    2013
  • 资助金额:
    $ 32.14万
  • 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
  • 批准号:
    9298690
  • 财政年份:
    2013
  • 资助金额:
    $ 32.14万
  • 项目类别:
Smartphone Delivered Meditation for BP Control Among Prehypertensives
智能手机为高血压前期患者提供控制血压的冥想
  • 批准号:
    9066182
  • 财政年份:
    2013
  • 资助金额:
    $ 32.14万
  • 项目类别:
Fit Body and Soul: A Lifestyle Intervention for Diabetes Prevention Conducted Thr
身心健康:预防糖尿病的生活方式干预措施
  • 批准号:
    7560284
  • 财政年份:
    2008
  • 资助金额:
    $ 32.14万
  • 项目类别:
Sociodemographic Regulation of CV Function and Structure
CV功能和结构的社会人口学调节
  • 批准号:
    7587401
  • 财政年份:
    2007
  • 资助金额:
    $ 32.14万
  • 项目类别:
Sociodemographic Regulation of CV Function and Structure
CV功能和结构的社会人口学调节
  • 批准号:
    8208579
  • 财政年份:
    2007
  • 资助金额:
    $ 32.14万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 32.14万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了